DISSEMINATED ENTEROVIRAL INFECTION

DISSEMINATED ENTEROVIRAL INFECTION was reported 18 times

DISSEMINATED ENTEROVIRAL INFECTION is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 BCL-2 Inhibitor [EPC] 3 0.0000
1 CD20-directed Cytolytic Antibody [EPC] 11 0.0000
2 Tetracycline-class Drug [EPC] 1 0.0000
3 Alkylating Drug [EPC] 3 0.0000
4 Platinum-based Drug [EPC] 3 0.0000
5 Nucleoside Metabolic Inhibitor [EPC] 3 0.0000
6 Purine Antimetabolite [EPC] 1 0.0000
7 Interleukin-6 Receptor Antagonist [EPC] 1 0.0000
8 Corticosteroid [EPC] 8 0.0000
9 Kinase Inhibitor [EPC] 3 0.0000
10 Atypical Antipsychotic [EPC] 2 0.0000
11 Interleukin-4 Receptor alpha Antagonist [EPC] 2 0.0000
12 Vitamin D [EPC] 1 0.0000
13 Vitamin B12 [EPC] 1 0.0000
14 Vitamin C [EPC] 1 0.0000
15 Folate Analog Metabolic Inhibitor [EPC] 1 0.0000